These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2535119)

  • 1. A comparison of the high-performance liquid chromatography and RIA measurement of medroxyprogesterone acetate.
    Mould GP; Read J; Edwards D; Bye A
    J Pharm Biomed Anal; 1989; 7(1):119-22. PubMed ID: 2535119
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioavailability of medroxyprogesterone acetate from three oral dosage formulations.
    Stalker DJ; Welshman IR; Pollock SR
    Clin Ther; 1992; 14(4):544-52. PubMed ID: 1388093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of illegal medroxyprogesterone acetate-application in veal calves by residue analysis in adipose tissue using HPLC/RIA methods.
    Rapp M; Meyer HH
    Food Addit Contam; 1989; 6(1):59-69. PubMed ID: 2521473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of mass spectrometry and radioimmunoassay to measure medroxyprogesterone acetate in patients with endometrial cancer.
    Kärkkäinen J; Vesterinen E; Stenman UH; Adlercreutz H; Nieminen U; Widholm O
    Eur J Cancer; 1990; 26(9):975-7. PubMed ID: 2149024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific and sensitive determination of medroxyprogesterone acetate in human serum by gas chromatography-mass spectrometry.
    Dikkeschei LD; van Veelen H; Nagel GT; Willemse PH; Wolthers BG
    J Chromatogr; 1985 Nov; 345(1):1-10. PubMed ID: 2935550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of hydroxyprogesterone caproate, medroxyprogesterone acetate, and progesterone by reversed-phase high-pressure liquid chromatography.
    Das Gupta V
    J Pharm Sci; 1982 Mar; 71(3):294-7. PubMed ID: 6461754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bioavailability of an orally administered medroxyprogesterone acetate suspension.
    Antal EJ; Gillespie WR; Albert KS
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):257-9. PubMed ID: 6222996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of differences in bioavailability of medroxyprogesterone acetate preparations.
    Stockdale AD; Rostom AY
    Clin Pharmacokinet; 1989 Mar; 16(3):129-33. PubMed ID: 2524303
    [No Abstract]   [Full Text] [Related]  

  • 9. Liquid chromatographic determination of medroxyprogesterone acetate in tablets.
    Fatmi AA; Williams GV; Hickson EA
    J Assoc Off Anal Chem; 1988; 71(3):528-30. PubMed ID: 2968977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of medroxyprogesterone acetate in patients with advanced breast cancer.
    Utaaker E; Lundgren S; Kvinnsland S; Aakvaag A
    J Steroid Biochem; 1988 Oct; 31(4A):437-41. PubMed ID: 2971841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometric and high-performance liquid chromatographic studies of medroxyprogesterone acetate metabolites in human plasma.
    Sturm G; Häberlein H; Bauer T; Plaum T; Stalker DJ
    J Chromatogr; 1991 Jan; 562(1-2):351-62. PubMed ID: 1827448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved bioavailability of a new oral preparation of medroxyprogesterone acetate.
    Etienne MC; Milano G; René N; Benedetti MS; Efthymiopoulos C; Vo Van ML; Hurteloup P; Montcuquet P; Frenay M; Namer M
    J Pharm Sci; 1991 Dec; 80(12):1130-2. PubMed ID: 1839998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medroxyprogesterone acetate: steady-state pharmacokinetics bioequivalence of two oral formulations.
    Pollow K; Kreienberg R; Di Pietro N
    J Cancer Res Clin Oncol; 1989; 115(4):397-9. PubMed ID: 2527239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medroxyprogesterone acetate- and ethinylestradiol-induced changes in biliary bile acids of the rat studied by high-performance liquid chromatography.
    Baker PR; Vitale GC; Siow YF
    J Chromatogr; 1987 Dec; 423():63-73. PubMed ID: 2965158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple high-performance liquid chromatographic method for the determination of medroxyprogesterone acetate in human plasma.
    Read J; Mould G; Stevenson D
    J Chromatogr; 1985 Jun; 341(2):437-44. PubMed ID: 3161906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate in advanced breast cancer patients.
    Etienne MC; Milano G; Frenay M; Renee N; Francois E; Thyss A; Schneider M; Namer M
    J Clin Oncol; 1992 Jul; 10(7):1176-82. PubMed ID: 1535103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The plasma concentration of medroxyprogesterone acetate and ovarian function during treatment with medroxyprogesterone acetate in 5 and 10 mg doses.
    Wikström A; Green B; Johansson ED
    Acta Obstet Gynecol Scand; 1984; 63(2):163-8. PubMed ID: 6233840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medroxyprogesterone acetate does not perturb the profile of steroid metabolites in urine during pregnancy.
    Yovich JL; Willcox DL; Wilkinson SP; Poletti VM; Hähnel R
    J Endocrinol; 1985 Mar; 104(3):453-9. PubMed ID: 3156203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The medroxyprogesterone acetate serum level following various medroxyprogesterone acetate dose schedules in gynecologic oncology].
    Husslein P; Egarter C; Eppel W; Salzer H; Spona J
    Zentralbl Gynakol; 1988; 110(20):1277-82. PubMed ID: 2977043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medroxyprogesterone acetate plasma levels after a single oral administration of two drug formulations.
    Pannuti F; Strocchi E; Longhi A; Comparsi R; Camaggi CM
    Chemioterapia; 1986 Aug; 5(4):237-9. PubMed ID: 2945648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.